XML 35 R13.htm IDEA: XBRL DOCUMENT
v3.20.4

Balance Sheet Components | 12 Months Ended
--- | ---
Dec. 31, 2020
Balance Sheet Components |
Balance Sheet Components | Note 6. Balance Sheet Components Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets consisted of the following (in thousands):
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | December 31,
​ |  | 2020 |  | 2019
Prepaid clinical and research related expenses | ​ | $ | 3,517 | ​ | $ | 2,567
Prepaid insurance | ​ | ​ | 1,440 | ​ | ​ | 1,161
Other prepaid expenses | ​ |  | 1,009 | ​ |  | 1,057
Other receivable | ​ | ​ | 311 | ​ | ​ | 744
Prepaid expenses and other current assets | ​ | $ | 6,277 | ​ | $ | 5,529
​ Property and Equipment, Net Property and equipment, net consisted of the following (in thousands):
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | December 31,
​ |  | 2020 |  | 2019
Laboratory equipment | ​ | $ | 3,539 | ​ | $ | 2,947
Furniture and computer equipment | ​ |  | 648 | ​ |  | 512
Leasehold improvements | ​ |  | 748 | ​ |  | 863
Total property and equipment | ​ |  | 4,935 | ​ |  | 4,322
Less: accumulated depreciation and amortization | ​ |  | (3,473) | ​ |  | (2,641)
Property and equipment, net | ​ | $ | 1,462 | ​ | $ | 1,681
​ Depreciation expense for the years ended December 31, 2020, 2019, and 2018 was $789,000, $703,000 and $527,000, respectively. As of December 31, 2020, 2019 and 2018, $46,000, $37,000 and $200, respectively, of property and equipment, net, was located in Australia. The remainder of the Company’s property and equipment is located in the United States. Accrued Expenses and Other Payables Accrued expenses and other payables consisted of the following (in thousands):
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | December 31,
​ |  | 2020 | ​ | 2019
Accrued clinical and research related expenses | ​ | $ | 11,335 | ​ | $ | 7,232
Accrued employee related expenses | ​ |  | 6,413 | ​ |  | 4,637
Accrued professional service fees | ​ | ​ | 668 | ​ | ​ | 301
Accrued interest payable | ​ | ​ | — | ​ | ​ | 68
Other | ​ |  | 82 | ​ |  | 122
Total accrued expenses and other payables | ​ | $ | 18,498 | ​ | $ | 12,360
​

X
- References No definition available. + Details
Name: | us-gaap_BalanceSheetRelatedDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -URI http://asc.fasb.org/topic&trid=2122208 + Details
Name: | us-gaap_SupplementalBalanceSheetDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration